Publicacións (66) Publicacións de Manuel Hermida Prieto

2024

  1. Analysis of the Association between Copy Number Variation and Ventricular Fibrillation in ST-Elevation Acute Myocardial Infarction

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  2. Preliminary Investigation on Efficacy and Safety of Substance P-Coated Stent for Promoting Re-Endothelialization: A Porcine Coronary Artery Restenosis Model

    Tissue Engineering and Regenerative Medicine, Vol. 21, Núm. 1, pp. 53-64

2022

  1. Rare Variants in Genes of the Cholesterol Pathway Are Present in 60% of Patients with Acute Myocardial Infarction

    International Journal of Molecular Sciences, Vol. 23, Núm. 24

2021

  1. Systemic treatment of immune-mediated keratoconjunctivitis sicca with allogeneic stem cells improves the schirmer tear test score in a canine spontaneous model of disease

    Journal of Clinical Medicine, Vol. 10, Núm. 24

2020

  1. Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 39, Núm. 10, pp. 1100-1108

  2. Presence of bacterial DNA in thrombotic material of patients with myocardial infarction

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. AGT haplotype in ITGA4 gene is related to antibody-mediated rejection in heart transplant patients

    PLoS ONE, Vol. 14, Núm. 7

2018

  1. Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: Clinical efficacy and safety

    Veterinary Record, Vol. 183, Núm. 21, pp. 654

  2. Allogeneic adipose-derived mesenchymal stem cells (Horse Allo 20) for the treatment of osteoarthritis-associated lameness in horses: Characterization, safety, and efficacy of intra-articular treatment

    Stem Cells and Development, Vol. 27, Núm. 17, pp. 1147-1160

  3. Donor polymorphisms in genes related to B-cell biology associated with antibody-mediated rejection after heart transplantation

    Circulation Journal, Vol. 82, Núm. 5, pp. 1351-1359

  4. LIGHT/BTLA polymorphisms and antibody-mediated-rejection after heart transplantation

    Oncotarget

  5. Polymorphisms in genes related to the complement system and antibody-mediated cardiac allograft rejection

    Journal of Heart and Lung Transplantation, Vol. 37, Núm. 4, pp. 477-485

2017

  1. Macrophagic enhancement in optical coherence tomography imaging by means of superparamagnetic iron oxide nanoparticles

    Cardiology Journal, Vol. 24, Núm. 5, pp. 459-466

2016

  1. Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report

    Cardiology Journal, Vol. 23, Núm. 5, pp. 573-582

2015

  1. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes

    Veterinary Journal, Vol. 206, Núm. 3, pp. 385-390

  2. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Endoscopic and histological outcomes

    Veterinary Journal, Vol. 206, Núm. 3, pp. 391-397

2013

  1. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy

    Circulation Journal, Vol. 77, Núm. 9, pp. 2358-2365

2011

  1. Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy

    European Heart Journal, Vol. 32, Núm. 2, pp. 177-183

2010

  1. Diagnóstico genético en cardiopatías familiares

    Actualización en cardiología (Servicio de Publicaciones)

  2. Disease: Cardiomyopathy, hypertrophic

    Human Genetics